These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15560946)

  • 1. Formulation aspects of biodegradable polymeric microspheres for antigen delivery.
    Tamber H; Johansen P; Merkle HP; Gander B
    Adv Drug Deliv Rev; 2005 Jan; 57(3):357-76. PubMed ID: 15560946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.
    Jiang W; Gupta RK; Deshpande MC; Schwendeman SP
    Adv Drug Deliv Rev; 2005 Jan; 57(3):391-410. PubMed ID: 15560948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
    Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
    Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines.
    Waeckerle-Men Y; Groettrup M
    Adv Drug Deliv Rev; 2005 Jan; 57(3):475-82. PubMed ID: 15560953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of recombinant human growth hormone against emulsification-induced aggregation by Pluronic surfactants during microencapsulation.
    Wei G; Lu LF; Lu WY
    Int J Pharm; 2007 Jun; 338(1-2):125-32. PubMed ID: 17336005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping neutral microclimate pH in PLGA microspheres.
    Li L; Schwendeman SP
    J Control Release; 2005 Jan; 101(1-3):163-73. PubMed ID: 15588902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.
    Mundargi RC; Srirangarajan S; Agnihotri SA; Patil SA; Ravindra S; Setty SB; Aminabhavi TM
    J Control Release; 2007 May; 119(1):59-68. PubMed ID: 17331611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to achieve sustained and complete protein release from PLGA-based microparticles?
    Giteau A; Venier-Julienne MC; Aubert-Pouëssel A; Benoit JP
    Int J Pharm; 2008 Feb; 350(1-2):14-26. PubMed ID: 18162341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
    Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
    J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable microspheres alone do not stimulate murine macrophages in vitro, but prolong antigen presentation by macrophages in vitro and stimulate a solid immune response in mice.
    Luzardo-Alvarez A; Blarer N; Peter K; Romero JF; Reymond C; Corradin G; Gander B
    J Control Release; 2005 Dec; 109(1-3):62-76. PubMed ID: 16269200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
    Krishnamachari Y; Madan P; Lin S
    Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface-modified biodegradable microspheres for DNA vaccine delivery.
    Keegan ME; Saltzman WM
    Methods Mol Med; 2006; 127():107-13. PubMed ID: 16988450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable cationic microparticles for enhanced model antigen delivery to dendritic cells.
    Wischke C; Borchert HH; Zimmermann J; Siebenbrodt I; Lorenzen DR
    J Control Release; 2006 Sep; 114(3):359-68. PubMed ID: 16889866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly (DL-lactide-co-glycolide) based delivery systems for vaccines and drugs.
    Dhiman N; Dutta M; Khuller GK
    Indian J Exp Biol; 2000 Aug; 38(8):746-52. PubMed ID: 12557904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
    Díez S; Tros de Ilarduya C
    Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microencapsulation peptide and protein drugs delivery system.
    Dai C; Wang B; Zhao H
    Colloids Surf B Biointerfaces; 2005 Mar; 41(2-3):117-20. PubMed ID: 15737536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pluronic F127 gel effectively controls the burst release of drug from PLGA microspheres.
    Wang Y; Gao JQ; Chen HL; Zheng CH; Liang WQ
    Pharmazie; 2006 Apr; 61(4):367-8. PubMed ID: 16649559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
    Duvvuri S; Janoria KG; Mitra AK
    J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of synthetic biodegradable microparticulate vaccines: a roller coaster story.
    Johansen P; Martínez Gómez JM; Gander B
    Expert Rev Vaccines; 2007 Aug; 6(4):471-4. PubMed ID: 17668999
    [No Abstract]   [Full Text] [Related]  

  • 20. Flow-through ultrasonic emulsification combined with static micromixing for aseptic production of microspheres by solvent extraction.
    Freitas S; Rudolf B; Merkle HP; Gander B
    Eur J Pharm Biopharm; 2005 Oct; 61(3):181-7. PubMed ID: 16009542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.